HALOZYME THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 9097084, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2013-12-31) |
| Status | superseded |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:23.728018+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0f0dcf3f-52c4-46f5-b997-85c1a897f4ff
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-14-000033Retrieved: 2026-08-19T11:36:23.728018+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/accounts-receivable/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0f0dcf3f-52c4-46f5-b997-85c1a897f4ff
History
- no predecessors — first report